Is AMGN (Amgen Inc.) Halal or Haram?

Based on our AAOIFI-standard shariah screening, AMGN is Halal and considered permissible for Muslim investors. It passed all 4 of 4 compliance screens including business activity review, debt-to-market-cap ratio (29.94% vs ≤33% threshold), interest income ratio (0.00% vs ≤5% threshold), and cash & securities ratio (5.01% vs ≤33% threshold).

Amgen Inc. is a global biotechnology pioneer focused on discovering, developing, and manufacturing innovative human therapeutics. The company produces critical treatments across oncology, inflammation, and bone health, featuring blockbuster drugs like Enbrel for rheumatoid arthritis, Neulasta for cancer patients, and Prolia for osteoporosis. For Muslim investors, Amgen represents a solid Halal investment opportunity within the healthcare sector. The stock successfully passes all four AAOIFI screening criteria, meaning both its life-saving pharmaceutical business activities and its underlying financial structures align with Islamic finance principles. From a financial perspective, Amgen's balance sheet is compliant but requires standard monitoring. The company's debt-to-market capitalization sits at 29.9%, which is relatively close to the 33% AAOIFI ceiling, while its cash and securities ratio is very conservative at just 5.0%. Crucially, the company derives 0.00% of its revenue from interest income, ensuring exceptionally clean earnings from its core operations. Because Amgen's debt ratio approaches the 33% limit, halal investors should carefully monitor its leverage during quarterly earnings reports. An unexpected drop in market capitalization or a sudden increase in borrowing for acquisitions could potentially push the stock out of shariah compliance in the future. Amgen Inc. operates in the Healthcare sector under the Drug Manufacturers - General industry and is headquartered in Thousand Oaks, CA, US. The company is led by CEO Robert A. Bradway and employs approximately 28,000 people.

AMGN was screened using AAOIFI-based shariah compliance criteria. Four tests are applied: (1) Business Activity — the company's core business must not derive primary income from haram (prohibited) activities such as alcohol, gambling, tobacco, or interest-based finance. (2) Debt-to-Market-Cap — total debt must not exceed 33% of market capitalization. (3) Interest Income — interest income must not exceed 5% of total revenue. (4) Cash & Securities — cash and interest-bearing securities must not exceed 33% of market cap. AMGN passed 4 of these 4 screens.

AMGN has negligible interest income, so purification may not be necessary. However, it is always advisable to consult a qualified scholar regarding your specific investment situation.

AMGN was last screened on 2026-04-29. Shariah compliance status can change as companies report new financial data, acquire new businesses, or shift revenue streams. We recommend checking back periodically for the most up-to-date screening results.